Previous 10 | Next 10 |
IQVIA™ (NYSE:IQV) today announced the launch of OCE+, the first of several new advancements to its leading life science customer engagement platform. OCE+ adds IQVIA’s Next Best recommendation engine – a daily workflow tool providing AI-driven recommendations for en...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and contract services to the life sciences industry, today announced the appointment of Costa Panagos, to serve as president of its Research & Development S...
Dan Loeb's 13F portfolio value decreased from $18.32B to $14.33B this quarter. The number of positions decreased from 113 to 92. Third Point increased Amazon, RH, and Catalent while decreasing Upstart Holdings and Walt Disney during the quarter. The top three positions are at ~23%...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays Global Healthcare Conference in Miami, FL on Wednesday, March 16, 2022 at 1:35 p.m. ET. A live audio webcast o...
IQVIA (NYSE:IQV) announced an agreement today with argenx SE. The multi-year contract covers a unique collaboration for the development of new indications for VYVGART™ (efgartigimod alfa fcab), an FDA-approved neonatal Fc receptor blocker for the treatment of generalized myasthen...
IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry was named the top CRO in Overall Reputation by clinical trial sites around the world in the 2021 WCG CenterWatch Global Site Rela...
IQVIA (NYSE:IQV) today published its 2021 Environmental, Social, and Governance (ESG) Report . The annual report highlights the significant efforts the company has made in advancing healthcare globally, increasing the diversity and engagement of its workforce, and reducing its globa...
IQVIA is a recognized leader in providing advanced tech solutions to companies in the life sciences industry. The growing expenditure in healthcare to provide various solutions means companies such as IQVIA are set for parallel growth. With a strong financial foundation evidenced ...
Image source: The Motley Fool. IQVIA Holdings, Inc. (NYSE: IQV) Q4 2021 Earnings Call Feb 15, 2022 , 9:00 a.m. ET Operator Continue reading For further details see: IQVIA Holdings, Inc. (IQV) Q4 2021 Earnings Call Transcript
The following slide deck was published by IQVIA Holdings Inc. in conjunction with their 2022 Q4 earnings call. For further details see: IQVIA Holdings Inc. 2022 Q4 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...